Inter-observer agreement using the LI-RADS version 2018 CT treatment response algorithm in patients with hepatocellular carcinoma treated with conventional transarterial chemoembolization

被引:8
|
作者
Bartnik, Krzysztof [1 ,2 ]
Podgorska, Joanna [2 ]
Rosiak, Grzegorz [2 ]
Korzeniowski, Krzysztof [2 ]
Rowinski, Olgierd [2 ]
机构
[1] Med Univ Warsaw, Doctoral Sch, Warsaw, Poland
[2] Med Univ Warsaw, Dept Radiol 2, Ul Banacha 1a, PL-02097 Warsaw, Poland
关键词
TACE; Hepatocellular carcinoma; LI-RADS treatment response; CT; CRITERIA;
D O I
10.1007/s00261-021-03272-9
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Aim To determine inter-reader agreement in categorization of imaging features using the Liver Imaging Reporting and Data System (LI-RADS) treatment response (LR-TR) algorithm in patients with hepatocellular carcinoma (HCC) treated with conventional transarterial chemoembolization (cTACE). Methods Two radiologists used the LR-TR algorithm to assess 112 computed tomography (CT) examinations of 102 patients treated with cTACE. The inter-observer agreement in categorization of LR-TR features was assessed using kappa (kappa) statistics. Results There was substantial inter-observer agreement between the two reviewers using the LR-TR algorithm (kappa = 0.70; 95% CI 0.58-0.81). The two reviewers categorized tumors as non-viable in 37 (33.0%) and 39 (34.8%) of 112 examinations, viable in 58 (51.8%) and 62 (55.4%) examinations, and equivocal in 18 (16.1%) and 11 (9.8%) examinations, respectively. There was almost perfect inter-observer agreement for the LR-TR non-viable category (kappa = 0.80; 95% CI 0.68-0.92), substantial agreement for the viable category (kappa = 0.78 95% CI 0.67-0.90), and fair agreement for the equivocal category (kappa = 0.25; 95% CI 0.02-0.49). Conclusion The LR-TR algorithm conveys high degrees of inter-observer agreement for the assessment of CT imaging features in the viable and non-viable categories. Further refinement of indeterminate features may be necessary to improve the correct categorization of equivocal lesions.
引用
收藏
页码:115 / 122
页数:8
相关论文
共 50 条
  • [21] Comparison of the Treatment Response of Drug-Eluting Bead Transarterial Chemoembolization and Conventional Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma
    Adel, Hatem
    Shazlee, Muhammad K.
    Qamar, Saqib
    Hyder, Syed Muhammad Shahnawaz
    Razaque, Abdul
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [22] Evaluation of LI-RADS Version 2018 Treatment Response Algorithm for Hepatocellular Carcinoma in Liver Transplant Candidates: Intraindividual Comparison between CT and Hepatobiliary Agent-enhanced MRI
    Bae, Jae Seok
    Lee, Jeong Min
    Yoon, Jeong Hee
    Kang, Hyo-Jin
    Jeon, Sun Kyung
    Joo, Ijin
    Lee, Kyoung Bun
    Kim, Haeryoung
    RADIOLOGY, 2021, 299 (02) : 336 - 345
  • [23] Outcomes of Patients with Hepatocellular Carcinoma Treated with Conventional Transarterial Chemoembolization Using Guidance Software
    Miyayama, Shiro
    Yamashiro, Masashi
    Sugimori, Natsuki
    Ikeda, Rie
    Okimura, Kotaro
    Sakuragawa, Naoko
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2019, 30 (01) : 10 - 18
  • [24] Liver imaging reporting and data system (LI-RADS) v2018: Reliability and agreement for assessing hepatocellular carcinoma locoregional treatment response
    Abdelrahman, Ahmed S.
    Ekladious, Mena E. Y.
    Badran, Ethar M.
    Madkour, Sherihan S.
    DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2022, 103 (11) : 524 - 534
  • [25] Performance of LI-RADS Version 2018 on CT for Determining Eligibility for Liver Transplant According to Milan Criteria in Patients at High Risk for Hepatocellular Carcinoma
    Bae, Jae Seok
    Lee, Dong Ho
    Lee, Sang Min
    Suh, Kyung-Suk
    Lee, Kwang-Woong
    Yi, Nam-Joon
    Lee, Kyoung Bun
    Kim, Haeryoung
    Han, Joon Koo
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2022, 219 (01) : 86 - 96
  • [26] Post-treatment CT LI-RADS categories: predictors of overall survival in hepatocellular carcinoma post bland transarterial embolization
    William E. L. Ormiston
    Hooman Yarmohammadi
    Stephanie Lobaugh
    Juliana Schilsky
    Seth S. Katz
    Maria LaGratta
    Sara Velayati
    Junting Zheng
    Marinela Capanu
    Richard K. G. Do
    Abdominal Radiology, 2021, 46 : 3738 - 3747
  • [27] Post-treatment CT LI-RADS categories: predictors of overall survival in hepatocellular carcinoma post bland transarterial embolization
    Ormiston, William E. L.
    Yarmohammadi, Hooman
    Lobaugh, Stephanie
    Schilsky, Juliana
    Katz, Seth S.
    LaGratta, Maria
    Velayati, Sara
    Zheng, Junting
    Capanu, Marinela
    Do, Richard K. G.
    ABDOMINAL RADIOLOGY, 2021, 46 (08) : 3738 - 3747
  • [28] Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients
    Chernyak, Victoria
    Fowler, Kathryn J.
    Kamaya, Aya
    Kielar, Ania Z.
    Elsayes, Khaled M.
    Bashir, Mustafa R.
    Kono, Yuko
    Do, Richard K.
    Mitchell, Donald G.
    Singal, Amit G.
    Tang, An
    Sirlin, Claude B.
    RADIOLOGY, 2018, 289 (03) : 816 - 830
  • [29] Preoperative Nomogram Incorporating Clinical Factors, Serological Markers and LI-RADS MRI Features to Predict Early Recurrence of Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
    Sheng, Ye
    Wang, Qing
    Liu, Hai-Feng
    Chen, Wen-Hua
    He, Zhong-Ming
    Wang, Qi
    ACADEMIC RADIOLOGY, 2023, 30 (07) : 1288 - 1297
  • [30] CT texture analysis in predicting treatment response and survival in patients with hepatocellular carcinoma treated with transarterial chemoembolization using random forest models
    He An
    Inderjeet Bhatia
    Fei Cao
    Zilin Huang
    Chuanmiao Xie
    BMC Cancer, 23